ABSTRACT
Recently, the prostate and the diseases to which it is so prone seem to have come to the forefront. The level of public interest has risen swiftly and with it the opportunities for research funding. This, in tandem with the recent explosive development of molecular biology, has produced new insights into the causes of benign prostatic hyperplasia, prostate cancer and prostatitis. For example, a hereditary factor in the pathogenesis of prostate cancer has been localized to a region of the long arm of chromosome 193; this may account for the tendency for prostate cancer, like breast cancer, to run in certain families.
